Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals, Inc.
Plaintiff: NOVARTIS PHARMACEUTICALS CORPORATION
Defendant: MSN PHARMACEUTICALS, INC., MSN LABORATORIES PRIVATE LTD. and MSN LIFE SCIENCES PRIVATE LTD.
Case Number: 25-1927
Filed: July 14, 2025
Court: U.S. Court of Appeals, Federal Circuit
Nature of Suit: Patent - (ANDA) (Fed. Qst.)
Docket Report

This docket was last retrieved on December 30, 2025. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 30, 2025 Filing 33 MODIFIED ENTRY: CORRECTED CONFIDENTIAL RESPONSE BRIEF FILED by Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 12/30/2025 by email. [1137430]--[Edited 01/07/2026 by GWK - Reason: compliance review complete] [Kevin Warner] [Entered: 12/30/2025 12:43 PM]
December 30, 2025 Filing 32 MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 12/30/2025 by email. [1137428] --[Edited 01/07/2026 by GWK - Reason: compliance review complete] [Kevin Warner] [Entered: 12/30/2025 12:42 PM]
December 29, 2025 Opinion or Order Filing 31 ORDER granting motion to extend time to file brief [ # 29 ] filed by Appellant Novartis Pharmaceuticals Corporation. The reply brief is due 03/10/2026. No further extensions of time for the reply brief should be anticipated. Service as of this date by the Clerk of Court. [1137250] [NL] [Entered: 12/29/2025 05:00 PM]
December 29, 2025 Filing 30 NOTICE OF NON-COMPLIANCE: The submission of Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc., Response Brief [ # 27 ], Confidential Response Brief [28], is not in compliance with the rules of this court (see attached). Compliant document due on 01/06/2026. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [1137040] [GWK] [Entered: 12/29/2025 12:41 PM]
December 22, 2025 Filing 29 MOTION of Appellant Novartis Pharmaceuticals Corporation to extend the time to 03/10/2026 to file brief. Service: 12/22/2025 by email. [1136004] [25-1927] [Deanne Maynard] [Entered: 12/22/2025 09:52 AM]
December 19, 2025 Filing 28 CONFIDENTIAL RESPONSE BRIEF FILED by Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 12/19/2025 by email. [1135833] [25-1927] This document is non-compliant. See Doc No. [ # 30 ] [Kevin Warner] [Entered: 12/19/2025 01:56 PM]
December 19, 2025 Filing 27 RESPONSE BRIEF FILED by Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 12/19/2025 by email. [1135831] [25-1927] This document is non-compliant. See Doc No. [ # 30 ] [Kevin Warner] [Entered: 12/19/2025 01:54 PM]
December 18, 2025 Filing 26 Amended Certificate of Interest for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 12/18/2025 by email. [1135705] [25-1927] [Kevin Warner] [Entered: 12/18/2025 05:35 PM]
October 15, 2025 Filing 25 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 24 ] filed by Appellees MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc. and MSN Life Sciences Private Ltd. The response brief is due 12/19/2025. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [1121198] [GWK] [Entered: 10/15/2025 12:29 PM]
October 10, 2025 Filing 24 MOTION of Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc. to extend the time to 12/19/2025 to file brief. Service: 10/10/2025 by email. [1120635] [25-1927] [Kevin Warner] [Entered: 10/10/2025 04:25 PM]
September 12, 2025 Filing 23 MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Novartis Pharmaceuticals Corporation. Service: 09/12/2025 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1114380] --[Edited 09/15/2025 by GWK - Reason: compliance review complete] [Deanne Maynard] [Entered: 09/12/2025 12:00 PM]
September 12, 2025 Filing 22 Entry of Appearance for Deanne E. Maynard; Seth W. Lloyd; Rebecca W. Setrakian as counsel for Appellant Novartis Pharmaceuticals Corporation. Service: 09/12/2025 by email. [1114377] [25-1927] [Deanne Maynard] [Entered: 09/12/2025 11:52 AM]
July 28, 2025 Filing 21 Docketing Statement for the Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 07/28/2025 by email. [1104998] [25-1927] [Kevin Warner] [Entered: 07/28/2025 06:51 PM]
July 28, 2025 Filing 20 Docketing Statement for the Appellant Novartis Pharmaceuticals Corporation. Service: 07/28/2025 by email. [1104983] [25-1927] [Jared Stringham] [Entered: 07/28/2025 05:31 PM]
July 22, 2025 Opinion or Order Filing 19 ORDER The motion [ # 9 ] is denied, and the temporary injunction (ECF No. [ # 13 ]) is lifted. The Clerk of Court shall transmit a copy of this order to the merits panel assigned to these appeals. (Per Curiam). Service as of this date by the Clerk of Court. [1103773] [NL] [Entered: 07/22/2025 02:28 PM]
July 21, 2025 Filing 18 Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 07/21/2025 by email. [1103589] [25-1927] [Kevin Warner] [Entered: 07/21/2025 08:18 PM]
July 21, 2025 Filing 17 REPLY of Appellant Novartis Pharmaceuticals Corporation to response [ # 15 ]. Service: 07/21/2025 by email. [1103521] [25-1927] [Jared Stringham] [Entered: 07/21/2025 04:12 PM]
July 18, 2025 Filing 16 Confidential Appellees MSN's Opposition To Appellant Novartis Pharmaceuticals Corporation's Confidential Emergency Motion For Injunction Pending Appeal And To Expedite The Motion filed by Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc. corresponding to Doc. No. [ # 15 ]. Service: 07/18/2025 by email. [1103147] [25-1927] [Kevin Warner] [Entered: 07/18/2025 11:33 AM]
July 18, 2025 Filing 15 RESPONSE of Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc. to Doc No. [ # 9 ]. Service: 07/18/2025 by email. [1103145] [25-1927] [Kevin Warner] [Entered: 07/18/2025 11:23 AM]
July 15, 2025 Filing 14 Note to File: The following cases are consolidated: 2025-1927 lead, with 2025-1928 member. The parties must file all documents in the lead appeal only. [1102396] [25-1927, 25-1928] [GWK] [Entered: 07/15/2025 01:48 PM]
July 15, 2025 Opinion or Order Filing 13 ORDER filed directing MSN to respond to Novartis's motion [ # 9 ] no later than 12:00 p.m., July 18, 2025. Any reply is due no later than 5 p.m., July 21, 2025. MSN is temporarily enjoined from commercial marketing and sale of its generic version of Entresto pending this court's consideration of the Rule 8 motion. Novartis is directed to file a bond in the district court in an amount, and subject to terms and conditions, deemed appropriate by the district court. Appeal No. 2025-1927 and Appeal No. 2025-1928 are consolidated, and the official caption is reflected in the order. The parties should file one set of briefs for both appeals. (Per Curiam). Service as of this date by the Clerk of Court. [1102331] [25-1927, 25-1928] [NL] [Entered: 07/15/2025 11:38 AM]
July 15, 2025 Filing 12 Notice from Appellant Novartis Pharmaceuticals Corporation Reply in Support of Request for Immediate Administrative Injunction. Service: 07/15/2025 by email. [1102264] [25-1927] [Jared Stringham] [Entered: 07/15/2025 08:34 AM]
July 14, 2025 Filing 11 Notice from Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc. of Opposition to Immediate Stay and Injunction During Emergency Motion Briefing and Intent to Separately Respond to Motion. Service: 07/14/2025 by email. [1102258] [25-1927] [Kevin Warner] [Entered: 07/14/2025 09:29 PM]
July 14, 2025 Filing 10 Confidential Novartis Pharmaceuticals Corporation's Emergency Motion for Injunction Pending Appeal and to Expedite the Motion filed by Appellant Novartis Pharmaceuticals Corporation corresponding to Doc. No. [ # 9 ]. Service: 07/14/2025 by email. [1102190] [25-1927] [Jared Stringham] [Entered: 07/14/2025 04:20 PM]
July 14, 2025 Filing 9 MOTION of Appellant Novartis Pharmaceuticals Corporation for temporary injunction. Service: 07/14/2025 by email. [1102176] [25-1927] [Jared Stringham] [Entered: 07/14/2025 04:08 PM]
July 14, 2025 Filing 8 Entry of Appearance for Ronald M. Daignault; Richard Juang; Elizabeth Bernard; Richard C. Weinblatt as counsel for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 07/14/2025 by email. [1102148] [25-1927] [Ronald Daignault] [Entered: 07/14/2025 03:30 PM]
July 14, 2025 Filing 7 Notice of Related Case Information for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 07/14/2025 by email. [1102118] [25-1927] [Kevin Warner] [Entered: 07/14/2025 03:01 PM]
July 14, 2025 Filing 6 Certificate of Interest for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 07/14/2025 by email. [1102117] [25-1927] [Kevin Warner] [Entered: 07/14/2025 02:56 PM]
July 14, 2025 Filing 5 Entry of Appearance for William A. Rakoczy; Deanne M. Mazzochi; Kevin E. Warner as counsel for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 07/14/2025 by email. [1102110] [25-1927] [Kevin Warner] [Entered: 07/14/2025 02:50 PM]
July 14, 2025 Filing 4 Certificate of Interest for Appellant Novartis Pharmaceuticals Corporation. Service: 07/14/2025 by email. [1102079] [25-1927] [Jared Stringham] [Entered: 07/14/2025 02:20 PM]
July 14, 2025 Filing 3 Notice of Related Case Information for Appellant Novartis Pharmaceuticals Corporation. Service: 07/14/2025 by email. [1102074] [25-1927] [Jared Stringham] [Entered: 07/14/2025 02:17 PM]
July 14, 2025 Filing 2 Entry of Appearance for Jared L. Stringham; Nicholas N. Kallas; Christopher E. Loh; Christina Schwarz as counsel for Appellant Novartis Pharmaceuticals Corporation. Service: 07/14/2025 by email. [1102065] [25-1927] [Jared Stringham] [Entered: 07/14/2025 02:05 PM]
July 14, 2025 Filing 1 Appeal docketed. Received: 07/11/2025. [1101922] Entry of Appearance due 07/28/2025. Certificate of Interest is due on 07/28/2025. Docketing Statement due 07/28/2025. Appellant's brief is due 09/12/2025. [GWK] [Entered: 07/14/2025 11:23 AM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.

Search for this case: Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: NOVARTIS PHARMACEUTICALS CORPORATION
Represented By: Christina A. L. Schwarz
Represented By: Christopher Earl Loh
Represented By: Nicholas Nick Kallas
Represented By: Jared Levi Stringham
Represented By: Rebecca Weires Setrakian
Represented By: Deanne Maynard
Represented By: Seth W. Lloyd
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MSN PHARMACEUTICALS, INC.
Represented By: Kevin E. Warner Esq.
Represented By: Deanne M. Mazzochi
Represented By: Richard Juang
Represented By: William A. Rakoczy
Represented By: Richard Charles Weinblatt
Represented By: Ronald M. Daignault
Represented By: Elizabeth Bernard
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MSN LABORATORIES PRIVATE LTD.
Represented By: Kevin E. Warner Esq.
Represented By: Deanne M. Mazzochi
Represented By: Richard Juang
Represented By: William A. Rakoczy
Represented By: Richard Charles Weinblatt
Represented By: Ronald M. Daignault
Represented By: Elizabeth Bernard
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MSN LIFE SCIENCES PRIVATE LTD.
Represented By: Kevin E. Warner Esq.
Represented By: Deanne M. Mazzochi
Represented By: Richard Juang
Represented By: William A. Rakoczy
Represented By: Richard Charles Weinblatt
Represented By: Ronald M. Daignault
Represented By: Elizabeth Bernard
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?